Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermatogenesis-associated protein 7 (SPATA7) is a cytoplasmic scaffold protein discovered in spermatocytes and expressed in the retina, fallopian tube, and respiratory epithelium[3][4]. It plays a critical role in photoreceptor cell maintenance by ensuring correct localization of proteins involved in the connecting cilium (CC), which is essential for normal microtubule stability and photoreceptor survival[1][2][6]. SPATA7 forms part of a complex network with other ciliary proteins, such as RPGR and RPGRIP1, required for the integrity of the retinal CC[1][2]. Loss-of-function mutations in SPATA7 disrupt protein trafficking in photoreceptors, leading to rhodopsin mislocalization, endoplasmic reticulum (ER) stress, and rapid photoreceptor degeneration manifesting as Leber congenital amaurosis (LCA3) and juvenile retinitis pigmentosa in humans and mouse models[1][2][7]. The gene has two isoforms due to alternative splicing[7], and clinical interest centers on genetic testing and potential gene replacement therapies[7]. SPATA7 is not currently classified as a druggable target, but advances in retinal gene therapy may change that.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogenesis-associated protein 7 (SPATA7).